Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors. - Wikidata - awgldk - TriplyDB

Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors.

Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors.

http://www.wikidata.org/entity/Q43435447

about

Progress and perspectives on targeting nanoparticles for brain drug delivery.Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents Bioanalytical chemistry of cytokines--a review Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systems.Applications of functionalized fullerenes in tumor theranostics.Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance.Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.Biomedical Applications of Metal-Encapsulated Fullerene Nanoparticles.Neurological disorders and therapeutics targeted to surmount the blood-brain barrier Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiforme Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.Nanotechnology applications for glioblastoma.Current status and future developments of endohedral metallofullerenes.Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents.Detecting Chronic Post-Traumatic Osteomyelitis of Mouse Tibia via an IL-13Rα2 Targeted Metallofullerene Magnetic Resonance Imaging Probe.When metal clusters meet carbon cages: endohedral clusterfullerenes.MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer.A platform for specific delivery of lanthanide-scandium mixed-metal cluster fullerenes into target cells.Metallofullerenes: a new class of MRI agents and more?An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.Adamantylidene Addition to M3 N@Ih -C80 (M=Sc, Lu) and Sc3 N@D5h -C80 : Synthesis and Crystallographic Characterization of the [5,6]-Open and [6,6]-Open Adducts.Development of bioactive materials for glioblastoma therapy.Magnetic resonance molecular imaging for non-invasive precision cancer diagnosis

P2860

Q26740580-57B9D83C-B58B-4101-BCB8-AE11BD0AA3DA Q26824262-FC7AC907-0F7F-4E1A-A2BD-25CE3BC51380 Q26851317-71445E52-48FC-4533-A134-DF486A01EE06 Q30459082-6FAEF6EB-B67F-4065-B197-46F41E01CA1A Q30468506-94D53545-C1B7-4946-BD41-9BB735582DD5 Q30533932-0916EFCD-94BE-4132-89E0-80D7645010A2 Q30543786-37071127-8318-4757-B183-D375C9FFE2FC Q31151525-F34C5CE6-EFC4-4BF9-BF16-EE20BA1030D1 Q36119574-7658BBA5-A1EE-43B8-91D0-33C94148A2CC Q36251215-F7A5E75B-55B4-41EE-BD22-49B6118466E4 Q37142843-2B725F95-DA7D-4E1A-A5AA-00050DB0E66D Q38022853-CCE0242B-1F2B-42AA-899B-B44F3E187ACF Q38036083-E274C447-BD8C-4BC0-939D-71EA34690FB2 Q38187571-DB631C26-E9D2-44A2-8C64-322C2365C607 Q39035541-92C8A955-81AC-455C-A14D-95FA9ED73ABD Q39417065-1F0A3E56-CB5C-4BCA-8D52-43CFB6B1AFD9 Q40016483-5B04B0B9-83E1-46D5-A1FA-135F51D9E263 Q41686682-45F44D03-B663-477D-8D4A-2C30D967EF26 Q41951086-31C9280B-EDED-4E84-B747-EF4754351BF0 Q44948693-AF7FD511-B10C-4832-B0C8-0F09EE26034A Q45867084-DBE07AD1-5139-451C-BFB4-7BD415DC3F8C Q46046192-679B7EB9-1F4D-4FAE-81D8-92BCA0844A94 Q54955140-1A53978D-A6CD-449E-998D-30E713D28394 Q57152405-81D1ACAE-5049-4FA8-8200-A55DFBA3CE66

P2860

Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors.

http://www.wikidata.org/entity/Q43435447

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Conjugation of functionalized ...... ting and imaging glial tumors.

@en

Conjugation of functionalized ...... ting and imaging glial tumors.

@nl

type

label

Conjugation of functionalized ...... ting and imaging glial tumors.

@en

Conjugation of functionalized ...... ting and imaging glial tumors.

@nl

prefLabel

Conjugation of functionalized ...... ting and imaging glial tumors.

@en

Conjugation of functionalized ...... ting and imaging glial tumors.

@nl

P1433

Q43435447-AAFE4F1E-47C2-416B-A842-8EF65482A1AD

P1476

Q43435447-929B885A-072C-499C-9119-9602CFE3D939

P2093

Q43435447-067BC44F-3EBB-4343-B089-DBD436079A4F

Q43435447-15D22BF5-902B-40F5-A5FD-53C8B79CAF9B

Q43435447-2B921C6C-A297-4BA2-8563-6F382A8DF370

Q43435447-3D15C228-96A2-45A7-B141-B3563EAB30FA

Q43435447-883CD08C-EE48-4B79-A55E-19ACED5F25EF

Q43435447-8E3340E3-94B4-4237-A368-243B61FC7288

Q43435447-A2484343-986D-4ED8-92C5-18A92AFADEDD

Q43435447-B348C48C-62B3-4703-9C22-9A4FF8EB144B

Q43435447-B63E04AD-B644-412D-AB8C-8AD32F025CFF

Q43435447-C72A4BAB-6A3A-4FD9-BCFA-07E9EEAD4D37

P2860

Q43435447-00BADC9D-032A-4A1D-9667-0DC49E9524AD

Q43435447-2990C48A-87DA-4A34-8442-12D5DCB9F81E

Q43435447-5025D457-0456-4A75-9756-DB69A45C0AE5

Q43435447-5362F0CF-B903-4BB2-960C-FDB6AC449834

Q43435447-55A5F1EA-C188-4857-A27E-0B09FDA5EEBB

Q43435447-58A3F0BE-8025-4A75-B775-0ED8769A675D

Q43435447-5A8DFD25-C1DB-4460-8A0F-1A715E9A4AC3

Q43435447-5C9A62E1-8D7B-473B-970E-ECEE4FD1C40E

Q43435447-5D6BDBBF-45CA-458E-AC19-7D1ED38BF65D

Q43435447-5EBB8844-F6A3-4124-96C5-34EA499A30E0

P304

Q43435447-691D3162-D4A4-48F7-AF2F-755715EEF5B3

P31

Q43435447-1BC60FDC-C5F6-41C4-A899-D52663C1DB4C

P356

Q43435447-0EF09345-EDAF-4187-A796-63FBA7F22235

P433

Q43435447-D9489A88-38D2-45E2-BB32-56A7D846F0CF

P478

Q43435447-C6AEAFAF-1E52-41DF-90E3-A5BB786F1136

P50

Q43435447-E18EC0E3-9447-4D2E-AC4B-D53D1539E4DC

Q43435447-F16A8944-DF02-4008-A718-4D16B732573A

P577

Q43435447-EDC9D5D5-9758-4F09-8946-B25091444AD4

P698

Q43435447-F98AFDDF-A405-44A7-A3A5-5E4E02BACC12

P356

P1433

P1476

Conjugation of functionalized ...... ting and imaging glial tumors.

@en

P2093

Chun-Ying Shu

http://www.w3.org/2001/XMLSchema#string

Frank Corwin

http://www.w3.org/2001/XMLSchema#string

Harry C Dorn

http://www.w3.org/2001/XMLSchema#string

Jerry I Hirsch

http://www.w3.org/2001/XMLSchema#string

Jianfei Zhang

http://www.w3.org/2001/XMLSchema#string

Jiechao Ge

http://www.w3.org/2001/XMLSchema#string

John Wilson

http://www.w3.org/2001/XMLSchema#string

Michael D Shultz

http://www.w3.org/2001/XMLSchema#string

Panos P Fatouros

http://www.w3.org/2001/XMLSchema#string

Patricia Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents.

Lanthanoid endohedral metallofullerenols for MRI contrast agents.

First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.

A realistic brain tissue phantom for intraparenchymal infusion studies.

Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.

In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle.

Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.

Preparation and characterization of two new water-soluble endohedral metallofullerenes as magnetic resonance imaging contrast agents.

Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent.

Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast.

P304

449-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.10.134

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Scott C Henderson

Helen L Fillmore

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21542684

http://www.w3.org/2001/XMLSchema#string